Skip to main content
Open Access Publications from the University of California

Phase 1, multicenter, open-label, dose-escalation, study of marizomib (MRZ) and bevacizumab (BEV) in WHO grade IV malignant glioma (G4 MG).

  • Author(s): Bota, Daniela Annenelie;
  • Desjardins, Annick;
  • Mason, Warren P;
  • Fine, Howard Alan;
  • Reich, Steven D;
  • Trikha, Mohit
  • et al.
Main Content
For improved accessibility of PDF content, download the file to your device.
Current View